Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis

Background: Neoadjuvant therapy (NAT) represents a paradigm shift in the management of patients with pancreatic ductal adenocarcinoma (PDAC) with perceived benefits including a higher R0 rate. However, it is unclear whether NAT affects the sites and patterns of recurrence after surgery. This review...

Full description

Bibliographic Details
Main Authors: Bathiya Ratnayake, Alina Y. Savastyuk, Manu Nayar, Colin H. Wilson, John A. Windsor, Keith Roberts, Jeremy J. French, Sanjay Pandanaboyana
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
recurrence
neoadjuvant chemotherapy
pancreatic ductal adenocarcinoma
pancreatic surgery
Online Access:https://www.mdpi.com/2077-0383/9/7/2132

Internet

https://www.mdpi.com/2077-0383/9/7/2132

Similar Items